These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32743568)

  • 1. Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2.
    An X; Martinez-Paniagua M; Rezvan A; Fathi M; Singh S; Biswas S; Pourpak M; Yee C; Liu X; Varadarajan N
    bioRxiv; 2020 Jul; ():. PubMed ID: 32743568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2.
    An X; Martinez-Paniagua M; Rezvan A; Sefat SR; Fathi M; Singh S; Biswas S; Pourpak M; Yee C; Liu X; Varadarajan N
    iScience; 2021 Sep; 24(9):103037. PubMed ID: 34462731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 in mice.
    King RG; Silva-Sanchez A; Peel JN; Botta D; Meza-Perez S; Allie R; Schultz MD; Liu M; Bradley JE; Qiu S; Yang G; Zhou F; Zumaquero E; Simpler TS; Mousseau B; Killian JT; Dean B; Shang Q; Tipper JL; Risley C; Harrod KS; Feng R; Lee Y; Shiberu B; Krishnan V; Peguillet I; Zhang J; Green T; Randall TD; Georges B; Lund FE; Roberts S
    bioRxiv; 2020 Oct; ():. PubMed ID: 33052351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge.
    King RG; Silva-Sanchez A; Peel JN; Botta D; Dickson AM; Pinto AK; Meza-Perez S; Allie SR; Schultz MD; Liu M; Bradley JE; Qiu S; Yang G; Zhou F; Zumaquero E; Simpler TS; Mousseau B; Killian JT; Dean B; Shang Q; Tipper JL; Risley CA; Harrod KS; Feng T; Lee Y; Shiberu B; Krishnan V; Peguillet I; Zhang J; Green TJ; Randall TD; Suschak JJ; Georges B; Brien JD; Lund FE; Roberts MS
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
    Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
    mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.
    van der Ley PA; Zariri A; van Riet E; Oosterhoff D; Kruiswijk CP
    Front Immunol; 2021; 12():781280. PubMed ID: 34987509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
    Americo JL; Cotter CA; Earl PL; Liu R; Moss B
    Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2202069119. PubMed ID: 35679343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.
    Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Cordón PJ; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
    Front Immunol; 2022; 13():995235. PubMed ID: 36172368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents.
    Bošnjak B; Odak I; Barros-Martins J; Sandrock I; Hammerschmidt SI; Permanyer M; Patzer GE; Greorgiev H; Gutierrez Jauregui R; Tscherne A; Schwarz JH; Kalodimou G; Ssebyatika G; Ciurkiewicz M; Willenzon S; Bubke A; Ristenpart J; Ritter C; Tuchel T; Meyer Zu Natrup C; Shin DL; Clever S; Limpinsel L; Baumgärtner W; Krey T; Volz A; Sutter G; Förster R
    Front Immunol; 2021; 12():772240. PubMed ID: 34858430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
    Vesin B; Lopez J; Noirat A; Authié P; Fert I; Le Chevalier F; Moncoq F; Nemirov K; Blanc C; Planchais C; Mouquet H; Guinet F; Hardy D; Vives FL; Gerke C; Anna F; Bourgine M; Majlessi L; Charneau P
    Mol Ther; 2022 Sep; 30(9):2984-2997. PubMed ID: 35484842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants.
    Lam JY; Ng YY; Yuen CK; Wong WM; Yuen KY; Kok KH
    Emerg Microbes Infect; 2022 Dec; 11(1):964-967. PubMed ID: 35275039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
    Nagai M; Moriyama M; Ichinohe T
    mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses.
    Mao T; Israelow B; Suberi A; Zhou L; Reschke M; Peña-Hernández MA; Dong H; Homer RJ; Saltzman WM; Iwasaki A
    bioRxiv; 2022 Jan; ():. PubMed ID: 35118464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ChAdOx1-S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination.
    Cokarić Brdovčak M; Materljan J; Šustić M; Ravlić S; Ružić T; Lisnić B; Miklić K; Brizić I; Pribanić Matešić M; Juranić Lisnić V; Halassy B; Rončević D; Knežević Z; Štefan L; Bertoglio F; Schubert M; Čičin-Šain L; Markotić A; Jonjić S; Krmpotić A
    Eur J Immunol; 2022 Jun; 52(6):936-945. PubMed ID: 35304741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract.
    Jearanaiwitayakul T; Apichirapokey S; Chawengkirttikul R; Limthongkul J; Seesen M; Jakaew P; Trisiriwanich S; Sapsutthipas S; Sunintaboon P; Ubol S
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity.
    Scaglione A; Opp S; Hurtado A; Lin Z; Pampeno C; Noval MG; Thannickal SA; Stapleford KA; Meruelo D
    Front Immunol; 2021; 12():719077. PubMed ID: 34394127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    Lee W; Kingstad-Bakke B; Kedl RM; Kawaoka Y; Suresh M
    J Virol; 2021 Jul; 95(15):e0053021. PubMed ID: 33952647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models.
    Zhou R; Wang P; Wong YC; Xu H; Lau SY; Liu L; Mok BW; Peng Q; Liu N; Woo KF; Deng S; Tam RC; Huang H; Zhang AJ; Zhou D; Zhou B; Chan CY; Du Z; Yang D; Au KK; Yuen KY; Chen H; Chen Z
    EBioMedicine; 2022 Jan; 75():103762. PubMed ID: 34942445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal Delivery of Thermostable Subunit Vaccine for Cross-Reactive Mucosal and Systemic Antibody Responses Against SARS-CoV-2.
    Nguyen KG; Mantooth SM; Vrabel MR; Zaharoff DA
    Front Immunol; 2022; 13():858904. PubMed ID: 35592324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence.
    Focosi D; Maggi F; Casadevall A
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.